Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0331 | ||||
| Gene Name | SLC38A4 | ||||
| Protein Name | Sodium-coupled neutral amino acid transporter 4 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
| Synonyms | ATA3; Amino acid transporter A3; NAT3; Na(+)-coupled neutral amino acid transporter 4; PAAT; SLC38A4; SNAT4; Solute carrier family 38 member 4; System A amino acid transporter 3; System N amino acid transporter 3 | ||||
| DT Family | Amino Acid/Auxin Permease (AAAP) Family ; | ||||
| Tissue Specificity | Detected in embryonic and adult liver, and atlower levels in adult muscle, kidney and pancreas. Detected inplacenta syncytiotrophoblasts throughout gestation. Detected infetal blood vessels. | ||||
| Function | This sodium-dependent transporter mediates electrogenic symport of neutral amino acids and sodium ions. Has a broad specificity, with a preference for Ala, followed by His, Cys, Asn, Ser, Gly, Val, Thr, Gln and Met. May mediate sodium-independent transport of cationic amino acids, such as Arg and Lys. Amino acid uptake is pH-dependent, with low transport activities at pH 6. 5, intermediate at pH 7. 0 and highest between pH 7. 5 and 8. 5. | ||||
| Disease(s) | Short bowel syndrome [ICD-11: KB89.1] | ||||
| Endogenous Substrate(s) | Alanine; Histidine; Cysteine; Asparagine; Serine; Glycine; Valine; Threonine; Glutamine; Methionine | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
(ε) Exogenous Modulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 2 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
L-alanine
|
Approved | Drug Info | Glioma | 2A00.0 | [1] |
|
L-glutamine
|
Approved | Drug Info | Short bowel syndrome | KB89.1 | [1] |
| References | |||||
| 1 | Identification of SLC38A7 (SNAT7) protein as a glutamine transporter expressed in neurons. J Biol Chem. 2011 Jun 10;286(23):20500-11. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.